Omni Peptides
Pinealon
Couldn't load pickup availability
Pinealon is a synthetic tripeptide with the sequence Glu-Asp-Arg, originally developed based on studies of short regulatory peptides derived from pineal gland and brain tissue extracts. This research compound has attracted considerable scientific interest for its potential neuroprotective, geroprotective, and neuroregulatory properties. Preliminary and advanced preclinical studies suggest that Pinealon may normalize pineal gland function, modulate gene expression related to neuronal differentiation and apoptosis, enhance antioxidant defenses, improve cerebral microcirculation, and support brain tissue recovery under stress or aging conditions. Researchers utilize Pinealon in laboratory and animal models to investigate mechanisms of neuroprotection, age-related cognitive decline, pineal-hypothalamic interactions, and peptide-mediated epigenetic regulation in the central nervous system. As a research-grade compound, Pinealon is intended exclusively for in vitro and animal studies. Scientists value its extremely low molecular weight, high blood-brain barrier permeability, rapid onset of action, and utility in elucidating short peptide signaling in brain aging and neurorestoration.
Research Applications
Storage & Handling
Storage & Handling
Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
Beyond Use Date
Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.
— About this compound
Pinealon is a synthetic neuroprotective tripeptide.
Pinealon is a synthetic tripeptide with the sequence Glu-Asp-Arg, originally developed based on studies of short regulatory peptides derived from pineal gland and brain tissue extracts. This research compound has attracted considerable scientific interest for its potential neuroprotective, geroprotective, and neuroregulatory properties. Preliminary and advanced preclinical studies suggest that Pinealon may normalize pineal gland function, modulate gene expression related to neuronal differentiation and apoptosis, enhance antioxidant defenses, improve cerebral microcirculation, and support brain tissue recovery under stress or aging conditions. Researchers utilize Pinealon in laboratory and animal models to investigate mechanisms of neuroprotection, age-related cognitive decline, pineal-hypothalamic interactions, and peptide-mediated epigenetic regulation in the central nervous system. As a research-grade compound, Pinealon is intended exclusively for in vitro and animal studies. Scientists value its extremely low molecular weight, high blood-brain barrier permeability, rapid onset of action, and utility in elucidating short peptide signaling in brain aging and neurorestoration.
Research Applications
Where researchers apply it.
— Verified & Documented
Every vial is backed by a Certificate of Analysis.
Each lot is independently characterised by HPLC and mass spectrometry, with identity, mass and purity documented per batch and available on request.
Additional quality-control testing, including sterility, endotoxin and heavy metals, is conducted periodically across our product range.
Storage & Handling
Storage & Handling
Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.
Beyond Use Date
Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.